A 2-Part Trial of CVL-751 in Subjects With Parkinson's Disease

Clinical trial NCT04295642 · COMPLETED

Trial details

NCT number: NCT04295642
Sponsor: Cerevel Therapeutics, LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2020-01-08
Primary completion: 2021-07-23
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.